Floatz logo

Equine Atg

Liver Transplantation

University Hospital, ToulousePhase 4 / ApprovedDormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Liver Transplantation cohort.

Asset / SponsorPhaseRating
TACROLIMUS
The Second Hospital of Tangshan
Phase 4BBB
Giapreza
University of California, San Francisco
Phase 4BBB
Everolimus
Novartis Pharmaceuticals
Phase 3BB
Sitagliptin
University Health Network, Toronto
Phase 4BB
Semaglutide
University Health Network, Toronto
Phase 4BB

View all 35 →

Same molecule, other indications

Equine Atg is also rated in:

acute lymphoblastic leukemiaDormant
BBB
Indicative ·
72 / 100
View asset →
disease related to hematopoietic stem cell transplantDormant
BB
Indicative ·
68 / 100
View asset →
Hemoglobinuria, Paroxysmal Nocturnal (PNH)Dormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →